Sartorius Stedim Biotech Annual Shareholders' Meeting
March 26, 2024 | 12 pm CET | Aubagne
The combined Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A. was held at the company's headquarter in Aubagne, France.
Here you will find all information and documents, as well as access to the VOTACCES website via Planetshares by BNP Paribas.
If you assume that the documents available are incomplete, please contact us promptly at asm.ssb@sartorius.com.
A recording of the public webcast is available
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Information and Documents
Please note that the English versions of these documents are for your convenience only. The original legally binding documents are available on the French website.
Documents
- CEO Presentation PDF | 1.2 MB
- Voting Results (French version only) PDF | 37.1 KB
- Report of the Shareholders' Meeting PDF | 48.4 KB
1. Information to Shareholders
- 1.1 Notice of the meeting BALO (French version only) PDF | 443.0 KB
- 1.2 Notice of the meeting (in French) PDF | 653.2 KB
- 1.2 Notice of the meeting (Translation, for information purposes only) PDF | 553.7 KB
- 1.3 Agenda and Resolutions PDF | 567.0 KB
- 1.4 Vote form PDF | 431.6 KB
- 1.5 Request of documents by a shareholder PDF | 96.1 KB
- 1.6 Shareholders´ convening guide PDF | 1.9 MB
2. Documents available for the Annual Shareholders' Meeting
- 2.1 Annual financial statements of Sartorius Stedim Biotech S.A. PDF | 285.3 KB
- 2.2 Consolidated financial statements of the Sartorius Stedim Biotech Group PDF | 909.5 KB
- 2.3 Group management report PDF | 4.2 MB
- 2.4 Management report of the Sartorius Stedim Biotech S.A. PDF | 235.5 KB
- 2.5 Report of the Board on the Resolutions PDF | 432.1 KB
- 2.6 Complementary report of the Board of Directors PDF | 417.3 KB
- 2.7 Erratum dated 01/03/2024 to the 2023 Remuneration Report Tables of the Executive Directors PDF | 142.4 KB
- 2.8 Corporate Governance Report 2023 PDF | 656.4 KB
- 2.9 Statutory auditors’ report on the financial statements of Sartorius Stedim Biotech S.A. for the financial year ended 31.12.2023 PDF | 123.7 KB
- 2.10 Statutory auditors’ report on the consolidated statements of Sartorius Stedim Biotech Group for the financial year ended 31.12.2023 PDF | 140.5 KB
- 2.11 Statutory auditors’ report on the information disclosed in accordance with article L. 225-38 of the French Commercial Code PDF | 92.8 KB
- 2.12 Supplementary statutory auditors’ report on the share capital increase with cancellation of preferential subscription rights PDF | 200.6 KB
- 2.13 Total number of shares and voting rights making up the issued capital PDF | 71.8 KB